Chloe James

Professor

University of Bordeaux

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Chloe James is a faculty member at the University of Bordeaux in France. Her research primarily focuses on thrombotic complications in myeloproliferative neoplasms, cardiovascular risk factors such as clonal hematopoiesis, and the role of neutrophil extracellular traps in various diseases, including COVID-19. She has contributed significantly to the understanding of platelet dynamics and their implications in hematologic disorders, as well as the effects of anticoagulants in high-risk patient populations.

Articles (18)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Damien Luque Paz

FRANCE

View details

Antoine Dewitte

University of Bordeaux

FRANCE

View details

Alexandre Guy

Bordeaux University Hospital

FRANCE

View details

Virginie Siguret

Professor

Université Paris Descartes

FRANCE

View details

Olivier Mansier

University of Bordeaux

FRANCE

View details

Georges JOURDI

Clinical Pathologist & Ass. Prof. (MCU-PH)

Assistance Publique - Hôpitaux de Paris

FRANCE

View details

Grigoris Gerotziafas

Sorbonne Université

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Chloe James

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms

Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies.

Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.

Impaired balance between neutrophil extracellular trap formation and degradation by DNases in COVID-19 disease.

Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms.

Microrheology and structural quantification of hypercoagulable clots.

Platelet function studies in myeloproliferative neoplasms patients with <i>Calreticulin</i> or <i>JAK2</i> <sup>V617F</sup> mutation.

Adrenal insufficiency revealing bilateral adrenal hemorrhage related to JAK2 V617F-positive essential thrombocythemia: about two cases.

Benefice and pitfall of direct oral anticoagulants in very high-risk myeloproliferative neoplasms

Hemostatic Effects of Tranexamic Acid in Cesarean Delivery: An Ancillary Study of the TRAAP2 Study.

GFHT proposals on the practical use of argatroban — With specifics regarding vaccine-induced immune thrombotic thrombocytopaenia (VITT)

Hip fracture and DOAC level: A retrospective study of 72 cases

Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms

Regulation of Platelet Production and Life Span: Role of Bcl-xL and Potential Implications for Human Platelet Diseases.

Evaluation of the potential utility of the total thrombus-formation analysis system in comparison to the platelet function analyser in subjects with primary haemostatic defects.

Absence of JAK2V617F Mutated Endothelial Colony-Forming Cells in Patients With JAK2V617F Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis.

Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm.

Management and outcomes of 27 pregnancies in women with myeloproliferative neoplasms

Collaborators (7)

Damien Luque Paz

Antoine Dewitte

Alexandre Guy

Virginie Siguret

Olivier Mansier

Georges JOURDI

Grigoris Gerotziafas

Make your next move.